IRIDEX | Ophthalmology Lasers to Increase Performance & Optimize Your Practice

Medical Retina

IRIDEX provides office-based laser solutions for your retina practice. With the patented Fovea-friendly™ MicroPulse® laser technology there is a treatment option for the most common retinal diseases.


Medical Retina Solutions

Operating Room

IRIDEX offers high quality laser systems, EndoProbe® handpieces, and a portfolio of vitreoretinal consumables for precision surgery in the hospital and ASC.


Hospital & ASC Solutions

Glaucoma

IRIDEX laser systems provide traditional, MicroPulse, and transscleral laser solutions for the management of glaucoma.


Glaucoma Solutions

Comprehensive

IRIDEX products offer the versatility of traditional, MicroPulse, and transscleral laser options for the treatment of both glaucoma and retinal diseases.


Comprehensive Solutions

 

Latest News & Events

September 14, 2020: Webinar: MicroPulse Transscleral Laser Therapy for Glaucoma by Dr. Rajen Desai

August 17, 2020: Webinar: All-laser Approach to Glaucoma with Dr. Ike Ahmed, Dr. Jella An, and Dr. Mahmoud Khaim

August 5, 2020: Article: Cyclophotocoagulation in Pediatric Glaucoma by Albert S Khouri, MD

July 27, 2020: Article: Maximizing the benefits of technology by improving the user by Caesar Luo, MD

July 23, 2020: Press Release: IRIDEX to Report Second Quarter 2020 Financial Results on August 6, 2020

July 18, 2020: Study: The Effectiveness and Safety of Micropulse Cyclophotocoagulation in the Treatment of Ocular Hypertension and Glaucoma

May 12, 2020: Over 25 glaucoma specialists from around the world discuss MicroPulse TLT for glaucoma in a series of webinars

May 8, 2020: An update on recent MicroPulse laser therapy studies by Caesar Luo, MD

May 3, 2020: MicroPulse Transscleral Laser Therapy After Tube Shunt Surgery by Brian M. Jerkins, MD

April 28, 2020: IRIDEX to Report First Quarter 2020 Financial Results on May 11, 2020

April 23, 2020: Case Files: A Case of Iridocorneal Endothelial Syndrome by Matthew Rouse, MD

April 21, 2020: IRIDEX Announces the Appointment of Doris Engibous to its Board of Directors

March 25, 2020: IRIDEX Glaucoma training, a page with information, resources, and more

March 25, 2020: A message from our CEO about COVID-19 pandemic

March 23, 2020: Webinar on April 13, 2020 with Dr. Michael Giovingo: The revised MicroPulse P3® Device: What You Need to Know

March 19, 2020: Webinar on March 26, 2020 with Dr. Jason Bacharach: How I Am Treating Glaucoma During the COVID-19 Pandemic

March 6, 2020: The revised MicroPulse P3 Device featured on the latest episode of EyeWire News

February 28, 2020: IRIDEX to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020

February 26, 2020: IRIDEX Launches Revised MicroPulse P3® Device for Glaucoma

February 10, 2020: Meet MicroPulse TLT experts at AGS in Washington, DC on February 27-29, 2020

February 1, 2020: MicroPulse TLT Wetlab at ICGS in London on February 8, 2020

January 15, 2020: Webinar with Dr. Sandra Sieminski and Dr. Syril K. Dorairaj on January 28, 2020

January 13, 2020: IRIDEX Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2019

December 9, 2019: MicroPulse Trans-scleral Laser Therapy for Glaucoma

December 5, 2019: Peer-reviewed study: Outcomes of Micropulse Transscleral Cyclophotocoagulation in Eyes With Good Central Vision

November 18, 2019: Webinar with Dr. Brian Francis now available on-demand

October 30, 2019: Article by Dr. Nir Shoham-Hazon in The Ophthalmology highlights MicroPulse transscleral therapy

October 28, 2019: IRIDEX Announces Appointment of Robert Gunst as Chairman of the Board of Directors

October 24, 2019: IRIDEX to Report Third Quarter 2019 Financial Results on November 7, 2019

October 1, 2019: Meet Twenty MicroPulse therapy experts will be at the IRIDEX booth at AAO in San Francisco

September 28, 2019: Live webinar with Dr. Brian Francis about MicroPulse Transscleral Laser Therapy on October 3, 2019

September 11, 2019: MicroPulse® Transscleral Laser Therapy Will be Discussed in Various Presentations and Educational Events at ESCRS